⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 30, 2024Expert Review of Ophthalmology

Real-life study on dexamethasone intravitreal implant (Ozurdex) for macular edema at a Colombian reference center

Carlos M. Rangel Germán Mejía‐Salgado Luz Catherine Martinez Fernando Briceño M. Margarita Parra Daniela A. Esmeral-Ordoñez Fernando Del Real Juan D. Arias Clara L Varón Eduardo Villareal Virgilio Galvis Angélica M. Prada

View at Publisher

Ask AI

Bookmark

Share

Abstract

Purpose To evaluate the real-life safety, morphological, and visual outcomes of the dexamethasone intravitreal implant (Ozurdex) in patients with macular edema (ME) within a low-middle-income country (LMIC) setting.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rangel et al. (2024) studied this question.

synapsesocial.com/papers/68e67b96b6db64358760536d https://doi.org/10.1080/17469899.2024.2362162

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intravitreal Dexamethasone Implant in the Treatment of Diabetic Macular Edema Focusing on the Role of OCT Biomarkers2024
2Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative ReviewNarrative Review · 2022 · 22 citations
3Evaluation of the Effects of Intravitreal Application of an Ozurdex Implant in Patients with Macular Edema due to Retinal Vein Occlusion.Retrospective Study · 2026
4Dexamethasone implant in naive versus refractory patients with diabetic macular edema: a Meta-analysis2024 · 3 citations
5Clinical and optical coherence tomography biomarkers as prognostic factors in dexamethasone intravitreal implant for diabetic macular edema2024 · 8 citations

More related papers

Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion2024
Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study2024
Intravitreal dexamethasone sodium phosphate challenge to predict implant response in refractory diabetic macular edema: a pilot study2026

More from Expert Review of Ophthalmology

Toward patient-centered, phenotype-driven care for dry eye disease: a review of advances in artificial tear formulationThu,
Lifitegrast ophthalmic solution 5% for the treatment of the signs and symptoms of dry eye disease: a review of clinical trials and real-world evidenceThu,